LABCORP HOLDINGS INC.·4

Feb 10, 3:05 PM ET

Vaughn Bryan T 4

4 · LABCORP HOLDINGS INC. · Filed Feb 10, 2026

Research Summary

AI-generated summary of this filing

Updated

Labcorp (LH) EVP Vaughn Exercises 358 RSUs; 122 Shares Withheld

What Happened Vaughn Bryan T, EVP, Diagnostics at Labcorp Holdings (LH), had 358 restricted stock units (RSUs) convert to common stock in early February 2026 (180 RSUs on Feb 6 and 178 RSUs on Feb 7). To cover tax withholding, 61 shares were withheld on each tranche — 61 shares at $277.20 (value $16,909) and 61 shares at $274.01 (value $16,715) — totaling 122 shares withheld (~$33,624). The conversion/derivative entries are recorded as $0 disposals (reflecting the RSU-to-share settlement).

Key Details

  • Transaction dates: Feb 6, 2026 (180 RSUs converted; 61 shares withheld at $277.20) and Feb 7–9, 2026 (178 RSUs converted; 61 shares withheld at $274.01).
  • Shares reported converted: 180 + 178 = 358 RSUs converted to common stock.
  • Shares withheld for taxes: 61 + 61 = 122 shares; total cash value withheld ≈ $33,624.
  • Footnotes: F1–F5 indicate these were RSUs (1 RSU = 1 share), the RSUs vested on Feb 7, 2026, and withholding was used to satisfy tax obligations; the award vests in two equal annual installments beginning Feb 6, 2026.
  • Shares owned after the transactions: not specified in this filing.
  • Timeliness: Filing dated Feb 10, 2026 for transactions beginning Feb 6; Form 4s are normally due within two business days, so the Feb 6 conversion may have been reported after the typical deadline.

Context This was an award/vesting event (RSUs converting to shares) with shares withheld to cover tax liabilities — commonly a net settlement rather than an open-market sale. Such routine withholding to meet tax obligations does not necessarily signal a change in the insider’s view of the company. The filing records are factual conversions and tax withholdings, not purchases or open-market sales.

Insider Transaction Report

Form 4
Period: 2026-02-06
Vaughn Bryan T
EVP, Diagnostics
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-06+1805,326.57 total
  • Tax Payment

    Common Stock

    [F2]
    2026-02-06$277.20/sh61$16,9095,265.57 total
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-07+1785,443.57 total
  • Tax Payment

    Common Stock

    [F2]
    2026-02-09$274.01/sh61$16,7155,382.57 total
  • Exercise/Conversion

    Restricted Stock Unit

    [F1][F3][F4]
    2026-02-061803,802 total
    Common Stock (180 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F1][F5][F4]
    2026-02-071783,624 total
    Common Stock (178 underlying)
Footnotes (5)
  • [F1]Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
  • [F2]Stock withholding to satisfy tax withholding obligations.
  • [F3]The Restricted Stock Units that have vested were part of a grant that vests in two equal annual installments beginning on February 6, 2026.
  • [F4]This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
  • [F5]The Restricted Stock Units vested on February 7, 2026.
Signature
/s/ Kathryn W. Kyle, Attorney-in-Fact for Bryan T. Vaughn|2026-02-10

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT